TL011 in Severe, Active Rheumatoid Arthritis Patients

- Rheumatoid Arthritis
- Completed

Study Title: TL011 in Severe, Active Rheumatoid Arthritis Patients

Teva Identifier: RA-TL011-101 | 2009-015702-18

ClinicalTrials.gov Identifier: NCT01123070

Study Status: Completed

Trial Condition(s): Rheumatoid Arthritis

Interventions: Biological: TL011, anti CD20, for the treatment of rheumatoid arthritis | Biological: MabThera infusions

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 80 Years

Trial Duration: 02/01/2010 - 05/01/2012

Phase: Phase 1/2

Study Type

Interventional